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Dietary factors differentiate vitiligo patients with stable or active disease
M Daniel1, K Cedercreutz1, SM Rangel1, Y Ali1, KM Daftary1, E Dellacecca1, L van Horn2, S
Green3, I Le Poole1 and RV Kundu1 1 Dermatology, Northwestern University Feinberg School
of Medicine, Chicago, Illinois, United States, 2 Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States and 3 Internal Medicine, Rush University, Chicago, Illinois, United States
Vitiligo is mediated by T cells targeting melanocyte antigens. Depigmentation in vitiligoprone mice can be accelerated or delayed by oral antibiotics in vitiligo-prone, but not in
healthy mice. We questioned whether lifestyle factors influence microbiome composition and
the development of human vitiligo. Patients and controls matched for age, sex and skin type
were consented before administering dietary and lifestyle questionnaires, collecting skin and
stool samples and evaluating clinical parameters related to vitiligo. Five-20 individuals per
group were included per parameter. Patient VASI, BSA and VitiQol were measured. The
NHANES validated dietary questionnaire (DHQII) provided nutritional data that were
analyzed using R. DNA isolated from skin and stool samples was subjected to 16SrRNA and
shotgun sequencing. No significant differences between patient and control groups were
found for skin care parameters, household composition, occupation or diet. However, significant reductions in the % Parabacteroides and a trend towards reduced Bacteroides were
observed in patient stool. Correlation analysis revealed biologically and statistically significant differences in dietary composition between patients with active or stable disease.
Notable differences include elevated carbohydrate, total fat and cholesterol consumption and
caffeine intake among patients with stable disease. These patients also consumed more fruit.
Importantly, stable disease was associated with 80% increased dietary intake of vitamin B2
and Ca2+, each associated with a healthy gut. Meanwhile a strong trend towards increased
energy derived from dietary alcohol was found among patients with active disease. We
tentatively propose that reduced stress combined with increased dietary calcium and riboflavin can support a healthy gut and disease stabilization in vitiligo.

An analysis of dermatology resident population’s medical trainings and
degrees
B Cooper1, K Pulsipher1, C Presley2 and R Dellavalle3,4 1 Rocky Vista University College of
Osteopathic Medicine, Parker, Colorado, United States, 2 Division of Dermatology, Lehigh
Valley Health Network, Allentown, Pennsylvania, United States, 3 Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado, United States and 4 Dermatology
Service, VA Eastern Colorado Health Care System, Aurora, Colorado, United States
Thousands of medical students apply for residency each year in the United States (US). The
majority have graduated medical school and received a degree from a US based allopathic
program (US MD), a US based osteopathic program (US DO), or are international medical
graduates (IMG MD). The underrepresentation of US DO and IMG MD residents, compared with
US MD residents, within the field of dermatology has been well documented in the literature.
Numerous calls to action have both highlighted this disparity and advocated for an increase in
representation of US DO and IMG MD residents within dermatology. To assess recent trends, we
provide a ten year analysis of medical training background data of dermatology residents,
compared to total Graduate Medical Education (GME) residents. For the academic years of 20112021, the total number of GME and dermatology residents were recorded. The residents’
background medical training was determined through analysis of the Accreditation Council for
Graduate Medical Education (ACGME) Data Resource Book. Our results demonstrate that from
2011-2021, 90.41% of dermatology residents were US MD, 6.16% US DO, and 3.41% IMG
MD compared to 63.16% US MD, 11.94% US DO, and 24.84% IMG MD GME residents
overall. Improvements have been made from 2011-2021, as the representation of US DO and
IMG MD residents in dermatology increased from 2.0% to 10.7% for US DO’s and from 3.0% to
3.5% for IMG MD’s. While the percentage of US DO and IMG MD residents within dermatology
has been increasing, attention should be directed towards making the representation of these two
groups in dermatology similar to what is seen in other specialties. Future studies and endeavors
should attempt to increase the representation of US DO and IMG MD physicians within the field
of dermatology.
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Characteristics and reasons for litigations involving dermatitis: An exploratory
analysis
R Raiker1, K Jenkins2, H Pakhchanian3 and L Shen2 1 West Virginia University School of
Medicine, Morgantown, West Virginia, United States, 2 Boston University School of Medicine, Boston, Massachusetts, United States and 3 The George Washington University School
of Medicine and Health Sciences, Washington, District of Columbia, United States
Previous research has examined the causes and characteristics for litigation among patients
who listed psoriasis and cutaneous malignancies as reasons for lawsuits. However, reasons for
litigation among patients with any form of dermatitis have not been assessed. Therefore, the
goal was to assess this by an exploratory analysis using Westlaw, one of the largest online
legal databases. Search terms “dermatitis or eczema” were used. Cases with judges and
settlements were manually reviewed and excluded if dermatitis was unrelated to the overall
lawsuit. Demographics, prosecution reason, verdict, dermatitis type, and case payouts were
examined. 98 out of 155 cases met the inclusion criteria, ranging from years 1983-2021. 59%
of plaintiffs were female and most cases were in the West (30%). Juries returning plaintiff and
defendant verdicts were 37% and 43% respectively with others being settlements. Dermatitis
was the primary cause of litigation in 72% of cases and the most prevalent form involved was
contact dermatitis (62%) with minimal atopic dermatitis cases (5%). The median and mean
payout among cases was $25,000 and $224,781 respectively (range from $325-$5075000).
Top reasons for litigation included toxic exposure (41%), medical malpractice (32%), and
negligent business practices (16%). Subgroup analysis of toxic exposure cases revealed 42%
were from an adverse reaction to a product, 30% from an occupational hazard, and 27%
were from improper cosmetic services. Among medical malpractice cases: 81% were won by
defendants, 7% of overall defendants were dermatologists, and only 4% mentioned adverse
effects of topical steroids. The findings here demonstrate majority of plaintiff-won cases came
from lawsuits where patients suffered contact dermatitis and sued businesses. Additionally,
minimal cases involved atopic dermatitis, topical steroids side effects, or lawsuits against
physicians. Further research is warranted.

Utilization of teledermatology services for dermatological diagnoses during
the COVID-19 pandemic
A He1, TT Kim2 and K Nguyen1 1 Dermatology, The University of Texas Southwestern
Medical Center, Dallas, Texas, United States and 2 Naveen Jindal School of Management,
The University of Texas at Dallas, Richardson, Texas, United States
Little is known about trends in teledermatology adoption and use for managing dermatologic
patients, especially changes in use influenced by the COVID-19 pandemic. In this retrospective cohort study, we analyzed encounter data from the Healthjump dataset (containing
electronic health record data from throughout the US) for visits from November 2019 to July
2021 with a primary dermatology-related diagnosis. There was a striking rise in teledermatology use with the onset of the pandemic in February 2020, peaking in April 2021 with
2,178 teledermatology encounters (32.8% of all encounters). Subsequently, teledermatology
use waned. When compared to those with neoplastic skin diseases, patients with inflammatory skin diseases were more likely to be seen via teledermatology (OR 3.30, 95% CI 3.123.49). Certain demographic groups were less likely to receive care via teledermatology, such
as men (compared with females, OR 0.76, 95% CI 0.74-0.78) and patients 65 and older
(compared with those below 65, OR 0.59, 95% CI 0.57-0.62). Our work shows increased
adoption of teledermatology at the onset of the COVID-19 pandemic with decreasing use
over time. Future efforts are needed to ensure continued and expanded use of a valuable care
modality to reach vulnerable populations.
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Characterizing inpatient hospitalizations for hidradenitis suppurativa and
assessing the impact of outpatient dermatology care on hospitalizations
J Maghfour, V Liu, R Huggins and IH Hamzavi Dermatology, Henry Ford Health System,
Detroit, Michigan, United States
Introduction: Hidradenitis suppurativa (HS) is associated with a significant disease burden.
The use of high-cost settings care are common among HS patients. Objective: To explore
factors that may influence hospital admissions and readmissions among HS patients.
Methods: Using ICD-9/10 codes (705.83 and L73.2), we extracted the medical records of
adult HS patients who visited the Henry Ford Health System (HFHS) ED between 2010 and
2020. Results: Of the 100 HS patients, 52 (52%) were admitted to an inpatient service.
Hypertension (OR:2.55,95% CI:1.11-5.83, p value¼0.027), diabetes mellitus (OR:2.42, 95%
CI:1.05-5.61, p value ¼0.039), cellulitis (OR: 19.28, 95%CI:4.23-87.96 p<0.001), sepsis
(OR:10.25, 95%CI:1.34-89.24, p value¼0.025), and depression (OR:3.32, 95%CI:1.1010.04, p value ¼0.002) were significant predictors of admission. Chronic kidney disease
(OR:3.05, 95% CI:1.00-9.23,p value¼0.049), congestive heart failure (OR:4.06, 95%CI:1.1913.80, p value ¼0.025), coronary artery disease (OR:15.20, 95%CI:2.80-82.65, p value¼0.002), chronic obstructive pulmonary disease (OR:8.94, 95%: 1.51-52.86, p value
¼0.003), cellulitis (OR:4.62, 95%CI:1.66-12.88, p¼0.003), sepsis (OR:3.75, 95%CI:1.0213.82,p value ¼0.047), and depression (OR:4.50, 95%CI:1.54-13.18, p value¼0.006) were
positively associated with readmission. Those who received outpatient dermatology care had
a lower risk of being admitted (n¼87, 28.7% vs n¼13,100%, p <0.001) and readmitted
(n¼10, 11.5% vs n¼5, 38.5%, p value ¼0.0108). Discussion: In this study, we demonstrate
that certain comorbidities, that are common among HS patients, are significant determinants
of admission to an inpatient service. Furthermore, the increase access to outpatient dermatology care significantly reduces the likelihood of HS patients being admitted and readmitted.
Conclusion: The findings of this study illuminate the pivotal role of dermatologists in
improving patients’ health outcomes while minimizing the avoidable use of high-cost settings
care.
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